BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19159951)

  • 1. Malignant fibrous histiocytoma--pleomorphic sarcoma, NOS gene expression, histology, and clinical course. A pilot study.
    Daigeler A; Klein-Hitpass L; Stricker I; Müller O; Kuhnen C; Chromik AM; Steinstraesser L; Goertz O; Steinau HU; Lehnhardt M
    Langenbecks Arch Surg; 2010 Mar; 395(3):261-75. PubMed ID: 19159951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative RNA profiling of TBEV-infected neurons and astrocytes reveals potential pathogenic effectors.
    Selinger M; Věchtová P; Tykalová H; Ošlejšková P; Rumlová M; Štěrba J; Grubhoffer L
    Comput Struct Biotechnol J; 2022; 20():2759-2777. PubMed ID: 35685361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma.
    Nakayama R; Nemoto T; Takahashi H; Ohta T; Kawai A; Seki K; Yoshida T; Toyama Y; Ichikawa H; Hasegawa T
    Mod Pathol; 2007 Jul; 20(7):749-59. PubMed ID: 17464315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Malignant fibrous histiocytoma: pleomorphic sarcoma NOS or pleomorphic fibrosarcoma].
    Meister P
    Pathologe; 2005 Mar; 26(2):127-33. PubMed ID: 15702318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.
    Francis P; Namløs HM; Müller C; Edén P; Fernebro J; Berner JM; Bjerkehagen B; Akerman M; Bendahl PO; Isinger A; Rydholm A; Myklebost O; Nilbert M
    BMC Genomics; 2007 Mar; 8():73. PubMed ID: 17359542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP Study Group. Chromosomes and MorPhology.
    Mertens F; Fletcher CD; Dal Cin P; De Wever I; Mandahl N; Mitelman F; Rosai J; Rydholm A; Sciot R; Tallini G; Van den Berghe H; Vanni R; Willén H
    Genes Chromosomes Cancer; 1998 May; 22(1):16-25. PubMed ID: 9591630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pleomorphic high-grade soft tissue sarcomas: is the subclassification up to date?].
    Mechtersheimer G; Renner M; Penzel R; Schirmacher P
    Pathologe; 2011 Feb; 32(1):47-56. PubMed ID: 21234572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MFH revisited: outcome after surgical treatment of undifferentiated pleomorphic or not otherwise specified (NOS) sarcomas of the extremities -- an analysis of 140 patients.
    Lehnhardt M; Daigeler A; Homann HH; Schwaiberger V; Goertz O; Kuhnen C; Steinau HU
    Langenbecks Arch Surg; 2009 Mar; 394(2):313-20. PubMed ID: 18584203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of germline and tumor mutations of p53 gene in familial occurrence of soft tissue sarcomas.
    Kudawara I; Matsumine A; Ohzono K
    J Surg Oncol; 2007 Mar; 95(4):347-50. PubMed ID: 17192950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rat malignant fibrous histiocytoma (MFH)-derived cloned cell lines (MT-8 and MT-9) show different differentiation in mesenchymal stem cell lineage.
    Kotera T; Katou-Ichikawa C; Tennakoon AH; Tanaka M; Tanaka N; Izawa T; Kuwamura M; Yamate J
    Exp Toxicol Pathol; 2015 Oct; 67(10):499-507. PubMed ID: 26208870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary and metastatic high-grade pleomorphic sarcoma/malignant fibrous histiocytoma of the gastrointestinal tract: an approach to the differential diagnosis in a series of five cases with emphasis on myofibroblastic differentiation.
    Agaimy A; Gaumann A; Schroeder J; Dietmaier W; Hartmann A; Hofstaedter F; Wünsch PH; Mentzel T
    Virchows Arch; 2007 Nov; 451(5):949-57. PubMed ID: 17874130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global protein-expression profiling for reclassification of malignant fibrous histiocytoma.
    Kikuta K; Morioka H; Kawai A; Kondo T
    Biochim Biophys Acta; 2015 Jun; 1854(6):696-701. PubMed ID: 25173742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary malignant fibrous histiocytoma (myxofibrosarcoma/pleomorphic sarcoma not otherwise specified) of the breast: clinicopathologic study of 19 cases.
    Hartel PH; Bratthauer G; Hartel JV; Fanburg-Smith JC
    Ann Diagn Pathol; 2011 Dec; 15(6):407-13. PubMed ID: 21983422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy.
    Barretina J; Taylor BS; Banerji S; Ramos AH; Lagos-Quintana M; Decarolis PL; Shah K; Socci ND; Weir BA; Ho A; Chiang DY; Reva B; Mermel CH; Getz G; Antipin Y; Beroukhim R; Major JE; Hatton C; Nicoletti R; Hanna M; Sharpe T; Fennell TJ; Cibulskis K; Onofrio RC; Saito T; Shukla N; Lau C; Nelander S; Silver SJ; Sougnez C; Viale A; Winckler W; Maki RG; Garraway LA; Lash A; Greulich H; Root DE; Sellers WR; Schwartz GK; Antonescu CR; Lander ES; Varmus HE; Ladanyi M; Sander C; Meyerson M; Singer S
    Nat Genet; 2010 Aug; 42(8):715-21. PubMed ID: 20601955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling of human sarcomas: insights into sarcoma biology.
    Baird K; Davis S; Antonescu CR; Harper UL; Walker RL; Chen Y; Glatfelter AA; Duray PH; Meltzer PS
    Cancer Res; 2005 Oct; 65(20):9226-35. PubMed ID: 16230383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomere-maintenance mechanisms in soft-tissue malignant fibrous histiocytomas.
    Matsuo T; Shay JW; Wright WE; Hiyama E; Shimose S; Kubo T; Sugita T; Yasunaga Y; Ochi M
    J Bone Joint Surg Am; 2009 Apr; 91(4):928-37. PubMed ID: 19339578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional genomics identifies AMPD2 as a new prognostic marker for undifferentiated pleomorphic sarcoma.
    Orth MF; Gerke JS; Knösel T; Altendorf-Hofmann A; Musa J; Alba-Rubio R; Stein S; Hölting TLB; Cidre-Aranaz F; Romero-Pérez L; Dallmayer M; Baldauf MC; Marchetto A; Sannino G; Knott MML; Wehweck F; Ohmura S; Li J; Hakozaki M; Kirchner T; Dandekar T; Butt E; Grünewald TGP
    Int J Cancer; 2019 Feb; 144(4):859-867. PubMed ID: 30267407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indistinguishable genomic profiles and shared prognostic markers in undifferentiated pleomorphic sarcoma and leiomyosarcoma: different sides of a single coin?
    Carneiro A; Francis P; Bendahl PO; Fernebro J; Akerman M; Fletcher C; Rydholm A; Borg A; Nilbert M
    Lab Invest; 2009 Jun; 89(6):668-75. PubMed ID: 19290004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic undifferentiated pleomorphic sarcoma causing intraoperative stroke.
    Spaulding R; Koumoundouros T; Parker JC
    Ann Clin Lab Sci; 2013; 43(2):172-5. PubMed ID: 23694792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.